StockData
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd (RGC) stock

RGCNasdaqMedicinal Chemicals & Botanical Products
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.55−0.17 (-3.60%)

Close on Nov 17, 2026Market cap $2.26BP/E –Yield –

Regencell Bioscience gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Regencell Bioscience

Regencell Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Regencell Bioscience figures

See a number that looks wrong?